| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $250K | — |
| Cost of Revenue | $31K | — |
| Gross Profit | $219K | — |
| R&D Expense | $63.9M | — |
| SG&A Expense | $30.3M | — |
| Operating Income | -$181.3M | — |
| Pre-tax Income | -$175.2M | — |
| Income Tax | -$10.6M | — |
| Net Income | -$49.2M | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $329.2M | -38.7% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $513.0M | -19.9% |
| Total Assets | $2.29B | -7.2% |
| Current Liabilities | $17.9M | +49.0% |
| Total Liabilities | $131.9M | -5.9% |
| Stockholders' Equity | $655.6M | -16.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.6M | — |
| Capital Expenditures | $68.7M | — |
| Investing Cash Flow | -$168.7M | — |
| Financing Cash Flow | -$4.9M | — |
| Free Cash Flow | -$100.3M | — |
| EPS (Basic) | -$0.67 | — |
| EPS (Diluted) | -$0.67 | — |